Osteosarcoma incidence and survival rates from 1973 to 2004: Data from the surveillance, epidemiology, and end results program

Cancer

Volumn 115, Issue 7, 2009, Pages 1531-1543

  Mirabello, Lisa ^a   Troisi, Rebecca J ^a,b   Savage, Sharon A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Bone cancer; Epidemiology; Epidemiology, and end results; Incidence; Osteosarcoma; Surveillance; Survival

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER SURVIVAL; CHILD; ETHNICITY; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH ORGANIZATION; NEWBORN; OSTEOSARCOMA; PAGET BONE DISEASE; POPULATION RESEARCH; PRESCHOOL CHILD; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCHOOL CHILD; SECOND CANCER; STATISTICAL SIGNIFICANCE; SURVIVAL RATE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; ETHNIC GROUPS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; OSTEOSARCOMA; SEER PROGRAM; SEX FACTORS; SURVIVAL RATE;

EID: 63449118087     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24121     Document Type: Article

References (54)

1. Sweetnam R. Osteosarcoma. Br J Hosp Med. 1982;28:112, 16-21.
2. Mascarenhas L, Siegel S, Spector L, Arndt C, Femino D, Malogolowkin M. Malignant bone tumors: cancer in 15- to 29-year-olds in the United States. In: Bleyer A, OLM, Barr R, Ries LAG, eds. Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, Including SEER Incidence and Survival: 1975-2000. Bethesda, Md: National Cancer Institute; 2006:98-109. NIH Pub. No. 06-5767.
3. Dahlin DC, Unni KK. Bone Tumors: General Aspects and Data on 8,542 Cases, 4th ed. Springfield, Ill: Thomas; 1986.
4. Damron TA, Ward WG, Stewart A. Osteosarcoma, chon- drosarcoma, and Ewing's sarcoma. National Cancer Data Base report. Clin Orthop Relat Res. 2007;459:40-47.
5. Dorfman HA, Czerniak B. Bone cancers. Cancer. 1995;75(1 suppl):203-210.
6. Kramarova E, Stiller CA. The International Classification of Childhood Cancer. Int J Cancer. 1996;68:759-765.
7. Fletcher CDM, Unni KK, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Soft Tissue and Bone. Lyon, France: IARC Press; 2002.
8. Unni KK. Osteosarcoma. In: Dahlin DC, ed. Dahlin's Bone Tumors: General Aspects and Data on 11,087 Cases, 5th ed. Philadelphia, Pa: Lippincott-Raven; 1996:143-183.
9. Dorfman HA, Czerniak B. Bone Tumors. St Louis, Mo: Mosby; 1997.
10. Price CHG. Osteogenic sarcoma: an analysis of the age and sex incidence. Br J Cancer. 1955;9:558-574.
11. Sabanas AO, Dahin DC, Childs DS, Ivings JC. Postirradia- tion sarcoma of bone. Cancer. 1956;9:528-542.
12. Murray RO. Tumor and tumor-like lesions of bone. In: Sutton D, Grainger AG, eds. A Textbook of Radiology, 2nd ed. New York, NY: Churchill Livingstone; 1975:109-137.
13. Huvos AG. Osteogenic sarcoma of bones and soft tissues in older persons. A clinicopathologic analysis of 117 patients older than 60 years. Cancer. 1986;57:1442-1449.
14. Hayden JB, Hoang BH. Osteosarcoma: basic science and clinical implications. Orthop Clin North Am. 2006;37:1-7.
15. Gurney JG, Swensen AR, Bulterys M. Malignant bone tumors. In: Reis LAG, Smith MA, Gurney JG, et al, eds. Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program, 1975-1995. Be- thesda, Md: National Cancer Institute SEER Program; 1999:99-110. NIH Pub. No. 99-4649.
16. Polednak AP. Human biology and epidemiology of childhood bone cancers: areview. Hum Biol. 1985;57:l-26.
17. Hanson MR, Mulvihill JJ. Epidemiology of Cancer in the
18. Young. New York, NY: Masson; 1982.
19. Glass AG, Fraumeni JF. Epidemiology of bone cancer in children. J Natl Cancer Inst. 1970;44:187-199.
20. Kramer S, Meadows AT, Jarret P, Evans AE. Incidence of childhood cancer: experience of a decade in a population- based registry. J Natl Cancer Inst. 1983;70:49-55.
21. Young JL Jr, Ries LG, Silverberg E, Horn JW, Miller RW. Cancer incidence, survival, and mortality for children younger than age 15 years. Cancer. 1986;58:598-602.
22. Homa DM, Sowers MR, Schwartz AG. Incidence and survival rates of children and young adults with osteogenic sarcoma. Cancer. 1991;67:2219-2224.
23. Gurney JG, Severson RK, Davis S, Robison LL. Incidence of cancer in children in the United States. Cancer. 1995;75:2186-2195.
24. Gatta G, Capocaccia R, Coleman MP, Ries LAG, Berrino F. Childhood cancer survival in Europe and the United States. Cancer. 2002;95:1767-1772.
25. Foster L, Dall GF, Reid R, Wallace WH, Porter DE. Twentieth-century survival from osteosaroma in children: trends from 1933 to 2004. J Bone Joint Surg. 2007;89- B:1234-1238.
26. Herzog CE. Overview of sarcomas in the adolescent and young adult population. J Pediatr Hematol Oncol. 2005;27:215-218.
27. Parkin DM, Stiller CA, Draper GJ, Bieber CA. The international incidence of childhood cancer. Int J Cancer. 1988;42:511-520.
28. Ajiki W, Hanai A, Tsukuma H, Hiyama T, Fujimoto I. Survival rates of childhood cancer patients in Osaka, Japan, 1975-1984. Jpn J Cancer Res. 1995;86:13-20.
29. Novakovic BUS. Childhood cancer survival, 1973-1987. Med Pediatr Oncol. 1994;23:480-486.
30. Larsson SE, Lorentzon R. The incidence of malignant primary bone tumors in relation to age, sex, and site: a study of osteogenic sarcoma, chondrosarcoma, and Ewing's sarcoma diagnosed in Sweden from 1958 to 1968. J Bone Joint Surg. 1974;56B:534-540.
31. Polednak AP. Primary bone cancer incidence in black and white residents of New York state. Cancer. 1985;55:2883-2888.
32. Blackwell JB, Threlfall TJ, McCaul KA. Primary malignant bone tumours in Western Australia, 1972-1996. Pathology. 2005;37:278-283.
33. Ji J, Hemminki K. Familial risk for histology-specific bone cancers: an updated study in Sweden. Eur J Cancer. 2006;42:2343-2349.
34. Linabery AM, Ross JA. Trends in childhood cancer incidence in the US (1992-2004). Cancer. 2007;112:416-432.
35. Surveillance, Epidemiology, and End Results Program of the National Cancer Institute. SEER Registries: Surveillance Research Program, National Cancer Institute. Bethesda, Md: National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch; 2007. Available at: http://seer.cancer.gov/registries/ Accessed on November 25, 2008.
36. Surveillance Research Program. National Cancer Institute SEER*Stat Software, version 6.3.6. Bethesda, Md: National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch; 2007.
37. Day JC. Population Projections of the United States by Age, Sex, Race and Hispanic Origin, 1995 to 2050, US Bureau of the Census, Current Population Reports, P25-1130. Washington, DC: US Government Printing Office; 1996.
38. World Health Organization. International Classification of Diseases for Oncology, 3rd ed. Geneva, Switzerland: World Health Organization; 2000.
39. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence-SEER 13 Regs Limited-Use, November 2006 Submission (1992-2004)- Linked to County Attributes-Total US, 1969-2004 Counties. Bethesda, Md: National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch; released April 2007, based on the November 2006 submission.
40. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence-SEER 9 Regs Limited-Use, November 2006 Submission (1973-2004)- Linked to County Attributes-Total US, 1969-2004 Counties.Bethesda,Md:NationalCancerInstitute, DCCPS, Surveillance Research Program, Cancer Statistics Branch; released April 2007, based on November 2006 submission.
41. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence-SEER 17 Regs Limited-Use, November 2006 Submission (1973-2004 varying)- Linked to County Attributes-Total US, 1969-2004 Counties. Bethesda, Md: National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch; released April 2007, based on the November 2006 submission. Available at: www.seer.cancer.gov. [Access date].
42. Miller RW. Contrasting epidemiology of childhood osteo- sarcoma, Ewing's sarcoma, and rhabdomyosarcoma. Nat Cancer Inst Monogr. 1981;56:9-15.
43. Hamre MR, Severson RK, Chuba P, Lucas DR, Thomas RL, Mott MP. Osteosarcoma as a second malignant neoplasm. Radiother Oncol. 2002;65:153-157.
44. Grimer RJ, Cannon SR, Taminiau AM, et al. Osteosar- coma over the age of forty. Eur JCancer. 2003;39:157-163.
45. Healey JH, Buss D. Radiation and pagetic osteogenic sarcomas. Clin Orthop Relat Res. 1991;270:128-134.
46. Hanson MF, Seton M, Merchant A. Osteosarcoma in Paget's disease of bone. J Bone Mineral Res. 2006;21(suppl 2):P58-P63.
47. Okada K, Hasegawa T, Nishida J, et al. Osteosarcomas after the age of 50: a clinicopathologic study of 64 cases-an experience in northern Japan. Ann Surg Oncol. 2004;11:998-1004.
48. deSantos LA, Rosengren JE, Wooten WB, Murray JA. Osteogenic sarcoma after the age of 50: a radiographic evaluation. AJR Am J Roentgenol. 1978;131:481-484.
49. Weinfield MS, Dudley HR. Osteogenic sarcoma: a follow- up study of the 94 cases observed at the Massachusetts General Hospital from 1920-1960. J Bone Joint Surg. 1962;44:269-276.
50. Aegerter E, Kirkpatrick JA. Orthopedic Disease, 4th ed. Philadelphia, Pa: Saunders, 1975.
51. Dahlin DC, Coventry MB. Osteogenic sarcoma: a study of 6 hundred cases. J Bone Joint Surg. 1967;49A:101-110.
52. Taylor WF, Ivins JC, Pritchard DJ, Dahlin DC, Gilchrist GS, Edmonson JH. Trends and variability in survival among patients with osteosarcoma: a 7-year update. Mayo Clin Proc. 1985;60:91-104.
53. Gatta G, Capocaccia R, Stiller C, Kaatsch P, Berrino F, Terenziani M; the EUROCARE Working Group. Childhood cancer survival trends in Europe: a EUROCARE Working Group study. J Clin Oncol. 2005;23:3742-3751.
54. Ferrari S, Palmerini E. Adjuvant and neoadjuvant combination chemotherapy for osteogenic sarcoma. Curr Opin Oncol. 2007;19:341-346.